Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Billion Photos / Shutterstock Creative Medical (NASDAQ: CELZ ) stock is rocketing higher on Wednesday thanks to clearance for a new clinical trial . That clearance comes from the FDA and covers CELZ-...
This week got off to a wild start, and Tuesday’s volatility from Fed Chair Jerome Powell’s commentary sent markets on a wild ride. While things have settled down a bit, there are still plenty of potential catalysts ahead this week. Many of those events center around central banker s...
Creative Medical Technology ( NASDAQ: CELZ ) said it received Institutional Review Board (IRB) approval to proceed with its phase 1/2 trial of cell therapy CELZ-201 to treat type 1 diabetes. The company noted that the U.S. Food and Drug Administration (FDA) had previously cl...
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes PR Newswire Company reaches next clinical trial milestone for treatment of Type 1 Diabetes with the first novel all...
Creative Medical Technology ( NASDAQ: CELZ ) on Thursday said the U.S. FDA had cleared the company's investigational new drug application to initiate a clinical trial with its AlloStem cell therapy for type 1 diabetes. Shares of the micro-cap biotech gained 9.1% to $0....
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes PR Newswire AlloStem™ represents the first novel allogenic cellular ...
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line PR Newswire PHOENIX , Oct. 20, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a biotechnology company focused on a regenerative approac...
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study PR Newswire --Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for ...
Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study PR Newswire Three-Year Follow Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients receiving OvaStem® Procedure for Treating Primary Ovarian I...
3 Penny Stocks to Add to Your July Watchlist Finding penny stocks to buy in 2022 can be a challenge. The stock market has had several big runs since its low in March 2020, but, we have seen a major bearish rally as of late. And because of this, finding the best penny stocks to buy with ...
News, Short Squeeze, Breakout and More Instantly...
Creative Medical Technology Holdings Inc. Company Name:
CELZ Stock Symbol:
OTCMKTS Market:
Creative Medical Technology Holdings Inc. Website:
PHOENIX, July 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ) , a leading commercial-stage biotechnology company focused on a regenerative approach to immunotherapy, urology, ne...
PHOENIX, June 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurolo...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...